(Q36960174)

17 August 2017

1 reference

title

Targeted modulators of the endogenous cannabinoid system: future medications to treat addiction disorders and obesity (English)

1 reference

17 August 2017

0 references

0 references

Alexandros Makriyannis

series ordinal

2

object named as

Alexandros Makriyannis

1 reference

17 August 2017

David R Janero

1

1 reference

PubMed ID

17915075

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Current Psychiatry Reports

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

5

1 reference

17 August 2017

365-373

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-007-0047-1

17 August 2017

0 references

cites work

An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

1 reference

12 December 2020

Involvement of the endocannabinoid system in drug addiction

1 reference

12 December 2020

Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders

1 reference

12 December 2020

Endocannabinoids and the regulation of their levels in health and disease

1 reference

12 December 2020

Endocannabinoids and synaptic function in the CNS.

1 reference

12 December 2020

Endocannabinoid system and alcohol addiction: pharmacological studies

1 reference

12 December 2020

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

1 reference

12 December 2020

Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases

1 reference

12 December 2020

Cannabinoid receptors as therapeutic targets.

1 reference

12 December 2020

Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

1 reference

12 December 2020

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.

1 reference

12 December 2020

The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).

1 reference

12 December 2020

Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers

1 reference

12 December 2020

Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers

1 reference

12 December 2020

Global burden of disease from alcohol, illicit drugs and tobacco

1 reference

12 December 2020

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

12 December 2020

Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase

1 reference

12 December 2020

1 reference

12 December 2020

Dopamine transporter ligands: recent developments and therapeutic potential

1 reference

12 December 2020

Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.

1 reference

12 December 2020

The role of the cannabinoid system in nicotine addiction.

1 reference

12 December 2020

Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions

1 reference

12 December 2020

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes

1 reference

12 December 2020

Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.

1 reference

12 December 2020

The obesity pipeline: current strategies in the development of anti-obesity drugs

1 reference

12 December 2020

Cannabinoid signalling

1 reference

12 December 2020

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

1 reference

12 December 2020

The endocannabinoid system and its therapeutic exploitation

1 reference

12 December 2020

Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation

1 reference

12 December 2020

Therapeutic opportunities through modulation of the endocannabinoid system.

1 reference

12 December 2020

The role of endocannabinoid transmission in cocaine addiction

1 reference

12 December 2020

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.

1 reference

12 December 2020

Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity

1 reference

12 December 2020

New insights into endocannabinoid degradation and its therapeutic potential

1 reference

12 December 2020

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa

1 reference

12 December 2020

Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes As

1 reference

12 December 2020

Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7.

1 reference

12 December 2020

Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet

1 reference

12 December 2020

1 reference

12 December 2020

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

12 December 2020

CB2 cannabinoid receptor mediation of antinociception.

1 reference

12 December 2020

Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis.

1 reference

12 December 2020

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

12 December 2020

Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3' region of the DRD2 gene

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats

1 reference

12 December 2020

The pharmacology of cannabinoid receptors and their ligands: an overview

1 reference

12 December 2020

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

1 reference

12 December 2020

CB1 receptor antagonists for the treatment of nicotine addiction

1 reference

12 December 2020

Cannabinoid receptors as therapeutic targets

1 reference

12 December 2020

A biosynthetic pathway for anandamide

1 reference

12 December 2020

Cannabinoid pharmacology: the first 66 years

1 reference

12 December 2020

Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine

1 reference

12 December 2020

Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol

1 reference

12 December 2020

Endocannabinoid system and opioid addiction: behavioural aspects.

1 reference

12 December 2020

Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment

1 reference

12 December 2020

The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats

1 reference

12 December 2020

The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

1 reference

12 December 2020

10.1007/S11920-007-0047-1

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17915075